Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast
Vidya C. Sinha(The University of Texas MD Anderson Cancer Center), Helen Piwnica‐Worms(Centre for Cancer Biology), Dean Y. Maeda(Syntrix Biosystems (United States)), Florencia McAllister(The University of Texas MD Anderson Cancer Center), Amanda L. Rinkenbaugh(University of North Carolina at Chapel Hill), John A. Zebala(Syntrix Biosystems (United States)), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Yuan Qi(The University of Texas MD Anderson Cancer Center), Mingchu Xu(Children’s Institute), Xinhui Zhou(Zhejiang University), Jiansu Shao(The University of Texas MD Anderson Cancer Center), Sabrina L. Jeter-Jones(The University of Texas MD Anderson Cancer Center)
Cited by 21
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01
|Journal of Biological Chemistry|2000|541
Extracellular Histones Are Mediators of Death through TLR2 and TLR4 in Mouse Fatal Liver Injury
|The Journal of Immunology|2011|522